Subtype-specific characteristics and outcomes of liposarcoma: A population-based study using Japan's National Cancer Registry
Authors:
- 21 January 2026
- journal article
- Published by Elsevier in Journal of Orthopaedic Science
- Vol. 31 (4) , 916-923
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Center Japan
- National Cancer Center (31-A-14)
- National Cancer Center (2022-A-15)
This publication has 27 references indexed in Scilit:
- Clinical characteristics and development of a prognostic model for overall survival in pediatric and adolescent liposarcoma: a SEER database analysisArchives of Dermatological Research, 2024
- Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆Annals of Oncology, 2021
- Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trialThe Lancet Oncology, 2020
- Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trialThe Lancet, 2016
- Update on Liposarcoma: A review for cytopathologistsDiagnostic Cytopathology, 2011
- Pleomorphic liposarcomaCancer, 2011
- Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective studyThe Lancet Oncology, 2007
- Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978–2001: An analysis of 26,758 casesInternational Journal of Cancer, 2006
- Differential sensitivity of liposarcoma subtypes to chemotherapyEuropean Journal of Cancer, 2005
- Prognostic factors for patients with localized soft‐tissue sarcoma treated with conservation surgery and radiation therapyCancer, 2003